CD274 and small cell lung carcinoma: Bonanno et al 22 analyzed the PD-L1 expression levels in 104 SCLC patients using the 22C3 clone and reported that the number of PD-L1-positive cases was significantly higher in stage I‒III versus metastatic patients (32% vs. 13%).